Form4insider filings, from the source

SEC Form 4 · accession 0001396867-26-000004

BIO-RAD LABORATORIES, INC. · BIO BIO.B

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Roop Kalyan Lakkaraju
Officer — EVP, Chief Financial Officer
Period of report
Sep 4, 2026
Accepted (ET)
Sep 9, 2026 · 6:42 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000012208

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Bio-Rad A Common StockF1,F2Sep 5, 2026M1,370$0.00A3,956D
Bio-Rad A Common StockSep 5, 2026F559$386.11D3,397D
Bio-Rad A Common StockF1Sep 6, 2026M1,536$0.00A4,933D
Bio-Rad A Common StockSep 6, 2026F782$386.11D4,151D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4$0.00Sep 4, 2026A6,326A——Bio-Rad A Common Stock6,3266,326D
Restricted Stock UnitsF3,F5$0.00Sep 5, 2026M1,370D——Bio-Rad A Common Stock1,3704,110D
Restricted Stock UnitsF3,F5$0.00Sep 6, 2026M1,536D——Bio-Rad A Common Stock1,5363,072D

Explanation of responses